人类疾病的补充:已批准和即将推出的治疗方法
Erin E West1, Trent Woodruff2, Veronique Fremeaux-Bacchi3
1Complement and Inflammation Research Section, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA.
Lancet (London, England)
|November 18, 2023
概括
补体系统保护病原体, 但其失调导致炎症性疾病. 新的补充疗法对罕见和潜在的常见疾病具有前景.
科学领域:
- 免疫学
- 药理学
背景情况:
- 补体系统对于免疫防御和组织平衡至关重要.
- 不调节的补充活性有助于炎症和自身免疫性疾病.
- 针对补充系统的治疗效益是一个长期目标, 但药物批准率很低.
研究的目的:
- 审查开发补充疗法的进展和挑战.
- 突出新目标和新兴技术来补充药物开发.
- 讨论补充向疗法的潜在扩展到常见疾病.
主要方法:
- 对补充系统生物学和治疗学的科学文献进行审查.
- 对临床试验数据和药物批准趋势的分析.
- 讨论药物发现和开发技术的进展.
主要成果:
- 抗C5抗体eculizumab在治疗阴道性夜间血红蛋白尿和非典型的血液溶解综合征方面表现出成功.
- 增加对补充路径的理解已经确定了新的治疗点.
- 人们对新型补充疗法的兴趣和发展显而易见.
结论:
- 补充生物和药物开发技术的进步正在推动补充疗法的创新.
- 目前批准的药物主要针对罕见疾病,
- 针对补充系统仍然是一个有前途的策略来管理一系列疾病.
更多相关视频
11:58Initial Evaluation of Antibody-conjugates Modified with Viral-derived Peptides for Increasing Cellular Accumulation and Improving Tumor Targeting
Published on: March 8, 2018
7.7K
09:12High-Throughput Automated Multiplex Immunofluorescence Assays for Translational Research
Published on: June 10, 2025
62
相关概念视频
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Microorganisms in Medicine and Therapeutics
35
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
35
Drug Discovery: Overview
8.0K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
8.0K
Tumor Immunotherapy
530
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
530
Transducer Mechanism: Enzyme-Linked Receptors
2.5K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.5K
Clinical Trials: Overview
3.0K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.0K
